| scholarly article | Q13442814 |
| P2093 | author name string | Chidozie J Amuzie | |
| James J Pestka | |||
| P2860 | cites work | A family of cytokine-inducible inhibitors of signalling | Q24313168 |
| A new protein containing an SH2 domain that inhibits JAK kinases | Q24313242 | ||
| Comparative effects of the herbal constituent parthenolide (Feverfew) on lipopolysaccharide-induced inflammatory gene expression in murine spleen and liver | Q24812969 | ||
| Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene | Q28242402 | ||
| Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo | Q28571622 | ||
| Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding | Q28579041 | ||
| Role of insulin-like growth factors in embryonic and postnatal growth | Q29620034 | ||
| Report from SCOOP task 3.2.10 "collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states". Subtask: trichothecenes | Q33206352 | ||
| A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. | Q34241257 | ||
| Signal transduction via the growth hormone receptor | Q34331449 | ||
| Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance | Q34368943 | ||
| Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? | Q34432712 | ||
| Effect of processing on deoxynivalenol and other trichothecenes | Q34581228 | ||
| Regulations relating to mycotoxins in food: perspectives in a global and European context | Q34629115 | ||
| Microbial transformation of deoxynivalenol (vomitoxin) | Q35698112 | ||
| The risk assessment paradigm and its application for trichothecenes | Q35876868 | ||
| Deoxynivalenol: toxicology and potential effects on humans | Q36068650 | ||
| The IGF system in childhood: physiology and clinical implications. | Q36237365 | ||
| Metabolic effects of IGF-I deficiency: lessons from mouse models | Q36348502 | ||
| Quantitative ontogeny of murine insulin-like growth factor (IGF)-I, IGF-binding protein-3 and the IGF-related acid-labile subunit | Q36511869 | ||
| Growth hormone regulation of insulin-like growth factor-I gene expression may be mediated by multiple distal signal transducer and activator of transcription 5 binding sites | Q36578881 | ||
| Effect of deoxynivalenol (vomitoxin) on fertility, pregnancy, and postnatal development of Sprague-Dawley rats | Q36659263 | ||
| The trichothecenes and their biosynthesis. | Q36736219 | ||
| Alterations in hepatic production and peripheral clearance of IGF-I after endotoxin | Q71704384 | ||
| Elevated gene expression and production of interleukins 2, 4, 5, and 6 during exposure to vomitoxin (deoxynivalenol) and cycloheximide in the EL-4 thymoma | Q72100322 | ||
| Effects of vomitoxin (deoxynivalenol) and cycloheximide on IL-2, 4, 5 and 6 secretion and mRNA levels in murine CD4+ cells | Q72349426 | ||
| The effect of low-level deoxynivalenol on neurotransmitter levels measured in pig cerebral spinal fluid | Q72662005 | ||
| Role of the suppressor of cytokine signaling-3 in mediating the inhibitory effects of interleukin-1beta on the growth hormone-dependent transcription of the acid-labile subunit gene in liver cells | Q73413868 | ||
| [Effect of dietary selenium on the activity of UDP-glucuronosyltransferases and metabolism of mycotoxin deoxynivalenol in rats] | Q77589724 | ||
| Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. | Q36742060 | ||
| Role of interleukin-6 signalling in glucose and lipid metabolism | Q37048809 | ||
| Immunochemical assessment of deoxynivalenol tissue distribution following oral exposure in the mouse | Q37227550 | ||
| The acid-labile subunit is required for full effects of exogenous growth hormone on growth and carbohydrate metabolism | Q37244613 | ||
| Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation | Q37363276 | ||
| Induction of suppressors of cytokine signaling by the trichothecene deoxynivalenol in the mouse | Q37398547 | ||
| Rapid, sequential activation of mitogen-activated protein kinases and transcription factors precedes proinflammatory cytokine mRNA expression in spleens of mice exposed to the trichothecene vomitoxin | Q38357300 | ||
| Deoxynivalenol: rationale for development and application of a urinary biomarker | Q38441928 | ||
| Immunochemical assessment of mycotoxins in 1989 grain foods: evidence for deoxynivalenol (vomitoxin) contamination | Q38858093 | ||
| p38 Mitogen-activated protein kinase mediates IL-8 induction by the ribotoxin deoxynivalenol in human monocytes | Q40338627 | ||
| Transcriptional and posttranscriptional roles for p38 mitogen-activated protein kinase in upregulation of TNF-alpha expression by deoxynivalenol (vomitoxin). | Q40612967 | ||
| Role of double-stranded RNA-activated protein kinase R (PKR) in deoxynivalenol-induced ribotoxic stress response | Q40644043 | ||
| Tumor necrosis factor mediates hepatic growth hormone resistance during sepsis | Q40711804 | ||
| Superinduction of TNF-alpha and IL-6 in macrophages by vomitoxin (deoxynivalenol) modulated by mRNA stabilization | Q40813740 | ||
| Dissection of the pathologies induced by transmembrane and wild-type tumor necrosis factor in transgenic mice. | Q40977517 | ||
| Modulation of IL-1beta, IL-6 and TNF-alpha secretion and mRNA expression by the trichothecene vomitoxin in the RAW 264.7 murine macrophage cell line | Q41025841 | ||
| Effects of 8-week exposure of the B6C3F1 mouse to dietary deoxynivalenol (vomitoxin) and zearalenone | Q41358407 | ||
| Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture | Q42435114 | ||
| Influence of low-level exposure to Fusarium mycotoxins on selected immunological and hematological parameters in young swine | Q42492911 | ||
| Decreased acid-labile subunit (ALS) levels by endotoxin in vivo and by interleukin-1beta in vitro | Q42493242 | ||
| Differential cytokine mRNA expression in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): dose response and time course | Q42549060 | ||
| Pharmacokinetic fate of 14C-labeled deoxynivalenol in swine | Q42657809 | ||
| Survey of deoxynivalenol in U.S. 1993 wheat and barley crops by enzyme-linked immunosorbent assay | Q43326729 | ||
| Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates | Q43667170 | ||
| Interleukin-6-deficient mice develop mature-onset obesity | Q43851625 | ||
| Effects of tumor necrosis factor type 1 and 2 receptor deficiencies on anorexia, growth and IgA dysregulation in mice exposed to the trichothecene vomitoxin | Q44100760 | ||
| An improved method for the purification of the trichothecene deoxynivalenol (vomitoxin) from Fusarium graminearum culture | Q44271694 | ||
| Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency | Q44700384 | ||
| Deoxynivalenol induces p38 interaction with the ribosome in monocytes and macrophages. | Q44748189 | ||
| A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain | Q46115849 | ||
| Effects of diets with graded levels of deoxynivalenol on performance in growing pigs | Q46173255 | ||
| Ribotoxic stress response to the trichothecene deoxynivalenol in the macrophage involves the SRC family kinase Hck. | Q46384510 | ||
| Interleukin-1 inhibits the induction of insulin-like growth factor-I by growth hormone in CWSV-1 hepatocytes | Q46438821 | ||
| LPS priming potentiates and prolongs proinflammatory cytokine response to the trichothecene deoxynivalenol in the mouse | Q46594728 | ||
| Tissue distribution and proinflammatory cytokine induction by the trichothecene deoxynivalenol in the mouse: comparison of nasal vs. oral exposure | Q46629066 | ||
| Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of hepatic IGF-I synthesis | Q46809661 | ||
| Effect of the appetite stimulant cyproheptadine on deoxynivalenol-induced reductions in feed consumption and weight gain in the mouse | Q47309389 | ||
| Effect of intraperitoneal infusion of deoxynivalenol on feed consumption and weight gain in the pig. | Q47317131 | ||
| Comparison of the trichothecenes deoxynivalenol and T-2 toxin for their effects on brain biogenic monoamines in the rat | Q48103501 | ||
| Chronic feeding study of deoxynivalenol in B6C3F1 male and female mice. | Q51019603 | ||
| Mature-Onset Obesity in Interleukin-1 Receptor I Knockout Mice | Q61480334 | ||
| Primary Acid-Labile Subunit Deficiency due to RecessiveIGFALSMutations Results in Postnatal Growth Deficit Associated with Low Circulating Insulin Growth Factor (IGF)-I, IGF Binding Protein-3 Levels, and Hyperinsulinemia | Q61647785 | ||
| Investigations in the use of mice exposed to mycotoxins as a model for growing pigs | Q67559691 | ||
| The role of intestinal microflora in the metabolism of trichothecene mycotoxins | Q68022101 | ||
| Increased serum clearance and degradation of 125I-labeled IGF-I in protein-restricted rats | Q68098712 | ||
| A short-term feeding study with deoxynivalenol (vomitoxin) using rats | Q69514435 | ||
| Dysregulation of IgA production and IgA nephropathy induced by the trichothecene vomitoxin | Q69542129 | ||
| The effect of deoxynivalenol on serotoninergic neurotransmitter levels in pig blood | Q71661418 | ||
| P433 | issue | 2 | |
| P921 | main subject | deoxynivalenol | Q420518 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 412-421 | |
| P577 | publication date | 2009-10-04 | |
| P1433 | published in | Toxicological Sciences | Q2446966 |
| P1476 | title | Suppression of insulin-like growth factor acid-labile subunit expression--a novel mechanism for deoxynivalenol-induced growth retardation | |
| P478 | volume | 113 |
| Q35209582 | A biomarker survey of urinary deoxynivalenol in China: the Shanghai Women's Health Study. |
| Q43007757 | A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults |
| Q33953295 | Aflatoxin exposure is inversely associated with IGF1 and IGFBP3 levels in vitro and in Kenyan schoolchildren |
| Q55032326 | Alleviation of mycotoxin biodegradation agent on zearalenone and deoxynivalenol toxicosis in immature gilts. |
| Q36752713 | Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YY |
| Q34440893 | Assessment of deoxynivalenol metabolite profiles in UK adults |
| Q33697738 | Body composition and hormonal effects following exposure to mycotoxin deoxynivalenol in the high-fat diet-induced obese mouse |
| Q35070893 | Characterization of deoxynivalenol-induced anorexia using mouse bioassay |
| Q57436926 | Climate change impacts on mycotoxin risks in US maize |
| Q35808575 | Deoxynivalenol Impairs Weight Gain and Affects Markers of Gut Health after Low-Dose, Short-Term Exposure of Growing Pigs |
| Q52845894 | Deoxynivalenol exposure assessment in a cohort of pregnant women from Bradford, UK. |
| Q35155832 | Deoxynivalenol-induced proinflammatory gene expression: mechanisms and pathological sequelae |
| Q37783539 | Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance |
| Q36801696 | Development and evaluation of a sensitive mycotoxin risk assessment model (MYCORAM). |
| Q47384909 | Effects of deoxynivalenol consumption on body weight and adiposity in the diet-induced obese mouse |
| Q33697732 | Evaluation of insulin-like growth factor acid-labile subunit as a potential biomarker of effect for deoxynivalenol-induced proinflammatory cytokine expression |
| Q27003457 | Food chain mycotoxin exposure, gut health, and impaired growth: a conceptual framework |
| Q38101247 | From the gut to the brain: journey and pathophysiological effects of the food-associated trichothecene mycotoxin deoxynivalenol |
| Q35681711 | Growth performance, serum biochemical profile, jejunal morphology, and the expression of nutrients transporter genes in deoxynivalenol (DON)- challenged growing pigs |
| Q39059345 | Influence of temperature and pH on the degradation of deoxynivalenol (DON) in aqueous medium: comparative cytotoxicity of DON and degraded product. |
| Q38856881 | Integrated Transcriptional and Proteomic Analysis of Growth Hormone Suppression Mediated by Trichothecene T-2 Toxin in Rat GH3 Cells |
| Q39372865 | JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin |
| Q35996593 | Murine Anorectic Response to Deoxynivalenol (Vomitoxin) Is Sex-Dependent |
| Q55110792 | Mycotoxins: cytotoxicity and biotransformation in animal cells |
| Q47161667 | Nitric oxide mediates apoptosis and mitochondrial dysfunction and plays a role in growth hormone deficiency by nivalenol in GH3 cells |
| Q60948315 | Pyrrolidine Dithiocarbamate (PDTC) Inhibits DON-Induced Mitochondrial Dysfunction and Apoptosis via the NF-B/iNOS Pathway |
| Q47160469 | Risks to human and animal health related to the presence of deoxynivalenol and its acetylated and modified forms in food and feed |
| Q85178238 | Stability of the mycotoxin deoxynivalenol (DON) during the production of flour-based foods and wheat flake cereal |
| Q36311606 | The Potential Role of Mycotoxins as a Contributor to Stunting in the SHINE Trial |
| Q38014991 | The role of biomarkers in evaluating human health concerns from fungal contaminants in food |
Search more.